TearScience
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, TearScience sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
TearScience: 6 sponsored US clinical trials, none currently recruiting.
TearScience sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Dry Eye Syndromes, with 1 trials.
Upper-quartile sponsor footprint
TearScience sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens Wearers
NCT02102464
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
NCT01808560
Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry Eye
NCT01521507
Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction
NCT01202747
Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye
NCT00832130
Diagnostic Evaluation of the Tear Film
NCT00761917
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
How the TearScience early-phase archive is shaped
6 indexed studies, none listed as recruiting (0% open); 6 completed (100%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Dry Eye Syndromes (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
TearScience: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
TearScience sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this TearScience page
6 registered trials is a research-attention snapshot, not an endorsement of TearScience or any single study.
- None of TearScience's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Dry Eye Syndromes is the condition TearScience studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dry Eye Syndromes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
TearScience pipeline card: 6 registered trials from official public datasets.Report a data error.